본문 바로가기
KERD
논문KCI 등재

The Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives: This study explored the association between a history of oligomenorrhea and onset of menopause and metabolic parameters.Methods: The study population was 605 postmenopausal women who were patients at the Menopause Clinic, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand between February 2015 and December 2015. A questionnaire was used to ask all women about their history of oligomenorrhea. The study also collected medical data, including weight, height, waist circumference, blood pressure, and blood glucose and lipid profile.Results: Of the 231 postmenopausal women with a complete data record, 31 had a history of oligomenorrhea and 200 did not. The age of onset of menopause was around 48 years in both groups. Prevalence of metabolic syndrome was 12.1%. More women with a waist circumference larger than 80 cm had a history of oligomenorrhea at the interview than women who had not, but a history of oligomenorrhea did not relate to other metabolic parameters. The adjusted odds ratio of a history of oligomenorrhea to waist circumference was 3.69 (95% confidence interval, 1.17-11.64). Conclusions: A history of oligomenorrhea did not affect the age at menopause, but was associated with waist circumference during menopause.

Abstract

Objectives: This study explored the association between a history of oligomenorrhea and onset of menopause and metabolic parameters.Methods: The study population was 605 postmenopausal women who were patients at the Menopause Clinic, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand between February 2015 and December 2015. A questionnaire was used to ask all women about their history of oligomenorrhea. The study also collected medical data, including weight, height, waist circumference, blood pressure, and blood glucose and lipid profile.Results: Of the 231 postmenopausal women with a complete data record, 31 had a history of oligomenorrhea and 200 did not. The age of onset of menopause was around 48 years in both groups. Prevalence of metabolic syndrome was 12.1%. More women with a waist circumference larger than 80 cm had a history of oligomenorrhea at the interview than women who had not, but a history of oligomenorrhea did not relate to other metabolic parameters. The adjusted odds ratio of a history of oligomenorrhea to waist circumference was 3.69 (95% confidence interval, 1.17-11.64). Conclusions: A history of oligomenorrhea did not affect the age at menopause, but was associated with waist circumference during menopause.

참고문헌 (38)

  1. Chandeying P, "Prevalence of conditions causing chronic anovulation and the proposed algorithm for anovulation evaluation", J Obstet Gynaecol Res, 41, pp.1074~1079 (2015)
  2. Taponen S, "Hormonal profile of women with self-reported symptoms of oligomenorrhea and", or hirsutism: Northern Finland birth cohort 1966 study, 2003, pp.88, 141~147
  3. Rickenlund A, "Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile", J Clin Endocrinol Metab, 90, pp.1354~1359 (2005)
  4. Taponen S, "Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and", or hirsutism: Northern Finland Birth Cohort 1966 Study, 2004, pp.19, 1083~1088
  5. March WA, "The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria", Hum Reprod, 25, pp.544~551 (2010)
  6. Baptiste CG, "Insulin and hyperandrogenism in women with polycystic ovary syndrome", J Steroid Biochem Mol Biol, 122, pp.42~52 (2010)
  7. Norman RJ, "Polycystic ovary syndrome", Lancet, 370, pp.685~697 (2007)
  8. Pantasri T, "Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome", J Med Assoc Thai, 93, pp.406~412 (2010)
  9. Biondi B, "Hypothyroidism as a risk factor for cardiovascular disease", Endocrine, 24, pp.1~13 (2004)
  10. Charmandari E, "Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?", Ann N Y Acad Sci, 1083, pp.37~53 (2006)
  11. Georgiopoulos GA, "Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors", Hypertension, 54, pp.98~105 (2009)
  12. Jiang XB, "Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study", Pituitary, 17, pp.232~239 (2014)
  13. Kim MS, "Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Semin Reprod Med, 27, pp.316~321 (2009)
  14. Souza LL, "Serum TSH levels are associated with cardiovascular risk factors in overweight and obese adolescents", J Pediatr (Rio J), 92, pp.532~538 (2016)
  15. Taponen S, "Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and", or hirsutism: Northern Finland Birth Cohort 1966 Study, 2004, pp.89, 2114~2118
  16. Hsu MI, "Changes in the PCOS phenotype with age", Steroids, 78, pp.761~766 (2013)
  17. Shah D, "Polycystic ovaries - beyond menopause", Climacteric, 17, pp.109~115 (2014)
  18. Li J, "Common diseases as determinants of menopausal age", Hum Reprod, 31, pp.2856~2864 (2016)
  19. Saxena R, "Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume", Hum Reprod, 30, pp.1697~1703 (2015)
  20. Tehrani FR, "Is polycystic ovary syndrome an exception for reproductive aging?", Hum Reprod, 25, pp.1775~1781 (2010)
  21. Solomon CG, "Menstrual cycle irregularity and risk for future cardiovascular disease", J Clin Endocrinol Metab, 87, pp.2013~2017 (2002)
  22. Mottillo S, "The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis", J Am Coll Cardiol, 56, pp.1113~1132 (2010)
  23. Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
  24. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
  25. Hara K, "A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population", Diabetes Care, 29, pp.1123~1124 (2006)
  26. Aekplakorn W, "Prevalence of obesity in Thailand", Obes Rev, 10, pp.589~592 (2009)
  27. Poehlman ET, "Menopause, energy expenditure, and body composition", Acta Obstet Gynecol Scand, 81, pp.603~611 (2002)
  28. Davis SR, "Understanding weight gain at menopause", Climacteric, 15, pp.419~429 (2012)
  29. Han TS, "A clinical perspective of obesity, metabolic syndrome and cardiovascular disease", JRSM Cardiovasc Dis, 5 (2016)
  30. Kyrou I, "Endotext" (2000), MDText.com, Inc.
  31. Rutter MK, "Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering", Metab Syndr Relat Disord, 12, pp.372~380 (2014)
  32. Aekplakorn W, "Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009", BMC Public Health, 11, pp.854~ (2011)
  33. Aekplakorn W, "Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009", Diabetes Care, 34, pp.1980~1985 (2011)
  34. Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)
  35. Indhavivadhana S, "Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women", Climacteric, 14, pp.58~65 (2011)
  36. Chompootweep S, "The menopausal age and climacteric complaints in Thai women in Bangkok", Maturitas, 17, pp.63~71 (1993)
  37. Gold EB, "Factors associated with age at natural menopause in a multiethnic sample of midlife women", Am J Epidemiol, 153, pp.865~874 (2001)
  38. Dumesic DA, "Cancer risk and PCOS", Steroids, 78, pp.782~785 (2013)

관련 논문AI추천

Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women박용규, Do Hoon Kim, Ga-Eun Nam, Hyo-Yun Nam, Kyung Do Han, Sang Su Lee, Sung Ho Lee, Young Eun Kim대한가정의학회 · Korean Journal of Family Medicine2016 · 제37권 제1호Relationship between Age at Menarche and Metabolic Syndrome in Premenopausal Women: Korea National Health and Nutrition Examination Survey 2013–2014김효은, 박승국, 박은주, 유선미, 최종기, 황윤서대한가정의학회 · Korean Journal of Family Medicine2018 · 제39권 제5호한국 여성의 조기 폐경이 대사증후군과 구성요소 유병 위험에 미치는 영향: 국민건강영양조사 제4~8기(2007~2021) 자료를 이용하여소은선동서간호학연구소 · 동서간호학연구지2024 · 제30권 제1호Effects of Age at First Childbirth and Other Factors on Central Obesity in Postmenopausal Women: The 2013–2015 Korean National Health and Nutrition Examination Survey광병규, 윤정원, 이왕진, 이주하, 장신해, 최유진대한가정의학회 · Korean Journal of Family Medicine2018 · 제39권 제3호Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal womenChan Soon Park, Gyu Chul Oh, Hae-Young Lee, Ho Kyung Sung, Hyeon Chang Kim, Kee Soo Kang, Kyoung Hwa Ha, Sang-Hyun Ihm, Sungha Park대한고혈압학회 · Clinical Hypertension2018 · 제24권 제4호Age at Natural Menopause and Related Factors in Isfahan, IranMohammad Reza Abdollahzadeh, Mojtaba Akbari, Parastoo Golshiri대한폐경학회 · 대한폐경학회지2016 · 제22권 제2호

이 간행물의 다른 논문 (10건)